AcetaZOLAMIDE
- Product NDC
- 51991-884
- 11-digit product format
- 519910884
- Labeler code
- 51991
- Product ID
- 51991-884_86e41dc5-d501-41f2-9a8a-0eb7b04f7763
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA207503
- Marketing category
- ANDA
- Marketing start
- 2020-09-01
- Marketing end
- 2022-08-31
- Substance
- ACETAZOLAMIDE
- Active strength
- 125 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-884-01 | 51991088401 | 100 TABLET in 1 BOTTLE (51991-884-01) | 100 tablet | 2020-09-01 | 2022-07-31 | No | No | Current |